icosapent ethyl — Patent Landscape
1
Drugs in class
122
Active US patents
50/100
Avg vulnerability
—
Annual revenue covered
Originators
Cliff calendar — next 15 years
4
27
72
30
46
33
Drugs ranked by patent estate
| Drug | Originator | Active patents | Avg vuln | Revenue | First cliff |
|---|---|---|---|---|---|
|
Vascepa
ICOSAPENT ETHYL
|
Amarin Pharms | 122 | 50 | — | 2027-05-31 |
Most attackable patents
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 12171738 | Vascepa | method of use | 64 | 2030-02-09 |
| 12171738 | Vascepa | method of use | 64 | 2030-02-09 |
| 11717504 | Vascepa | method of use | 59 | 2030-04-29 |
| 11717504 | Vascepa | method of use | 59 | 2030-04-29 |
| 11213504 | Vascepa | method of use | 59 | 2030-04-29 |
| 11213504 | Vascepa | method of use | 59 | 2030-04-29 |
| 9700537 | Vascepa | method of use | 58 | 2027-05-31 |
| 9700537 | Vascepa | method of use | 58 | 2027-05-31 |
| 9198892 | Vascepa | method of use | 58 | 2027-09-25 |
| 9198892 | Vascepa | method of use | 58 | 2027-09-25 |
Strongest defences
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 8298554 | Vascepa | formulation | 31 | 2030-04-29 |
| 8298554 | Vascepa | formulation | 36 | 2030-04-29 |
| 10555925 | Vascepa | method of use | 45 | 2033-06-28 |
| 9623001 | Vascepa | method of use | 45 | 2033-06-28 |
| 10278937 | Vascepa | method of use | 45 | 2033-06-28 |
| 10278936 | Vascepa | method of use | 45 | 2033-06-28 |
| 10668042 | Vascepa | method of use | 45 | 2033-06-28 |
| 9623001 | Vascepa | method of use | 45 | 2033-06-28 |
| 10786478 | Vascepa | method of use | 45 | 2033-06-28 |
| 10383840 | Vascepa | method of use | 45 | 2033-06-28 |
Related
- icosapent ethyl class hub (all drugs incl. pipeline)
- AI Patent Landscape — type "icosapent ethyl" for an AI exec memo
- Company Patent Rankings